Changes

no edit summary
Line 2,217: Line 2,217:  
|}<br />
 
|}<br />
   −
==WHO Classification of Tumours of the Central Nervous System Content==
+
==WHO Central Nervous System Tumours  (5th ed.) Content==
 
{| class="wikitable"
 
{| class="wikitable"
 
|-
 
|-
Line 2,228: Line 2,228:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
| Astrocytoma, IDH-mutant||Disease||
|9/20/21
  −
|
  −
|COMPLETE
  −
|
  −
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
  −
|9/22/2022
  −
|2021 template added
  −
|-
  −
|Paediatric-Type Diffuse High-Grade Gliomas
  −
|Overview
   
|
 
|
 
|
 
|
Line 2,246: Line 2,236:  
|
 
|
 
|
 
|
|2021 template added
   
|-
 
|-
|Diffuse Midline Glioma, H3 K27-Altered
+
| Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
|Disease
  −
|Laveniya Satgunaseelan (Linda Cooley - previous version)
   
|
 
|
 
|
 
|
|PENDING
   
|
 
|
|Laveniya Satgunaseelan (LS)
   
|
 
|
|2021 template added
  −
|-
  −
|Diffuse Hemispheric Glioma, H3 G34-Mutant
  −
|Disease
  −
|Xiaolin (Lynn) Hu
  −
|2/21/2022
   
|
 
|
|PENDING
   
|
 
|
|LS
   
|
 
|
|2021 template added
   
|-
 
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
+
| Glioblastoma, IDH-wildtype||Disease||
|Disease
   
|
 
|
 
|
 
|
Line 2,279: Line 2,254:  
|
 
|
 
|
 
|
|2021 template added
   
|-
 
|-
|Infant-Type Hemispheric Glioma
+
| Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
|Disease
   
|
 
|
 
|
 
|
Line 2,290: Line 2,263:  
|
 
|
 
|
 
|
|2021 template added
   
|-
 
|-
|Astrocytoma, IDH-Mutant
+
| Angiocentric glioma||Disease||
|Disease
+
|
|Riley Lochner (trainee), Shashi Shetty (mentor)
  −
|3/3/2022
   
|
 
|
|PENDING
   
|
 
|
|LS
   
|
 
|
|2021 template added
  −
|-
  −
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
  −
|Disease
  −
|Riley Lochner (trainee), Shashi Shetty (mentor)
  −
|3/3/2022
   
|
 
|
|PENDING
   
|
 
|
|LS
   
|
 
|
|2021 template added
   
|-
 
|-
|Ganglioglioma
+
| Polymorphous low-grade neuroepithelial tumour of the young||Disease||
|Disease
+
|
|Leila Moayed-Aloei
  −
|6/30/2022
   
|
 
|
|PENDING
   
|
 
|
|LS
   
|
 
|
|2021 template added
  −
|-
  −
|Pilocytic Astrocytoma
  −
|Disease
  −
|Jeremy Pulvers
  −
|9/13/2022
   
|
 
|
|PENDING
   
|
 
|
|LS
   
|
 
|
|2021 template added
  −
|-
  −
|}<br />
  −
  −
==WHO Classification of Soft Tissue and Bone Tumours Content==
  −
{| class="wikitable"
  −
|-
  −
!'''Disease'''!!'''Page Type'''!!'''Author'''
  −
!'''Date Assigned to Author'''
  −
!'''Target Completion Date'''
  −
!'''Author Content (Pending or Complete)'''
  −
!'''Date Completed by Author'''!!'''Associate Editor'''
  −
!'''Date of Last Editor Review'''
  −
!'''Notes'''
   
|-
 
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
+
| Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
|2/20/2022
   
|
 
|
|PENDING
   
|
 
|
|Alanna Church
   
|
 
|
 
|
 
|
|-
  −
|}<br />
  −
  −
==WHO Classification of Tumours of Breast Tumours Content==
  −
{| class="wikitable"
  −
|-
  −
!'''Disease'''!!'''Page Type'''!!'''Author'''
  −
!'''Date Assigned to Author'''
  −
!'''Target Completion Date'''
  −
!'''Author Content (Pending or Complete)'''
  −
!'''Date Completed by Author'''!!'''Associate Editor'''
  −
!'''Date of Last Editor Review'''
  −
!'''Notes'''
  −
|-
  −
|Adenoid Cystic Carcinoma
  −
|Disease||Katherine Geiersbach
  −
|10/12/02022
   
|
 
|
|PENDING
   
|
 
|
|Hui Chen
   
|
 
|
|2021 template added
   
|-
 
|-
|Secretory Carcinoma
+
| Diffuse midline glioma, H3 K27-altered||Disease||
|Disease
  −
|Hui Chen
  −
|10/12/2022
  −
|
  −
|PENDING
   
|
 
|
|Katherine Geiersbach
   
|
 
|
|2021 template added
  −
|-
  −
|}<br />
  −
  −
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
  −
{| class="wikitable sortable"
  −
!'''Gene'''
  −
!'''Author'''
  −
!'''Date Assigned to Author'''
  −
!'''Target Completion Date'''
  −
!'''Author Content (Pending or Complete)'''
  −
!'''Date Completed by Author'''
  −
!'''Associate Editor'''
  −
!'''Date of Last Editor Review'''
  −
!'''Notes'''
  −
|-
  −
|BCR
  −
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
  −
|8/10/18
   
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|ABL1
+
| Diffuse hemispheric glioma, H3 G34-mutant||Disease||
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
  −
|4/16/19
   
|
 
|
 
|
 
|
 
|
 
|
|-
  −
|RUNX1
  −
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
+
|-
|6/9/19
+
| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
|
   
|
 
|
 
|
 
|
|-
  −
|RUNX1T1
  −
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
  −
|5/23/19
   
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|MYH11
+
| Infant-type hemispheric glioma||Disease||
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
  −
|8/6/18
   
|
 
|
 
|
 
|
 
|
 
|
|-
  −
|FLT3
  −
|Kay Weng Choy
   
|
 
|
 
|
 
|
|Complete
+
|-
|
+
| Pilocytic astrocytoma ||Disease||
 
|
 
|
 
|
 
|
 
|
 
|
|-
  −
|NPM1
  −
|Kay Weng Choy
   
|
 
|
 
|
 
|
|Complete
   
|
 
|
 
|
 
|
 +
|-
 +
| High-grade astrocytoma with piloid features||Disease||
 
|
 
|
 
|
 
|
|-
  −
|TP53
  −
|Kay Weng Choy
   
|
 
|
 
|
 
|
|Complete
   
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
| Pleomorphic xanthoastrocytoma||Disease||
 
|
 
|
|-
  −
|DNMT3A
  −
|Kay Weng Choy
   
|
 
|
 
|
 
|
|Complete
   
|
 
|
 
|
 
|
Line 2,496: Line 2,354:  
|
 
|
 
|-
 
|-
|CEBPA
+
| Subependymal giant cell astrocytoma||Disease||
|Gordana
+
|
 
|
 
|
 
|
 
|
|Complete
   
|
 
|
 
|
 
|
Line 2,506: Line 2,363:  
|
 
|
 
|-
 
|-
|IDH1
+
| Chordoid glioma||Disease||
|Paul De Fazio
+
|
 
|
 
|
 
|
 
|
|Complete
   
|
 
|
 
|
 
|
Line 2,516: Line 2,372:  
|
 
|
 
|-
 
|-
|IDH2
+
| Astroblastoma, MN1-altered||Disease||
|Paul De Fazio
+
|
 
|
 
|
 
|
 
|
|Complete
   
|
 
|
 
|
 
|
Line 2,526: Line 2,381:  
|
 
|
 
|-
 
|-
|PML
+
| Ganglioglioma||Disease||
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
  −
|12/5/18
   
|
 
|
 
|
 
|
 
|
 
|
|-
  −
|RARA
  −
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
+
|-
|8/3/18
+
| Gangliocytoma||Disease||
|
   
|
 
|
 
|
 
|
|-
  −
|ETV6
  −
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
  −
|6/9/19
   
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|KIT
+
| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
  −
|10/1/18
   
|
 
|
 
|
 
|
 
|
 
|
|-
  −
|CBFB
  −
|Brian Davis
   
|
 
|
 
|
 
|
|Complete
+
|-
|8/2/18
+
| Dysembryoplastic neuroepithelial tumour||Disease||
|
   
|
 
|
 
|
 
|
|-
  −
|GATA2
  −
|Kay Weng Choy
   
|
 
|
 
|
 
|
|Complete
   
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
 
|
 
|
|-
  −
|PTEN
  −
|Beth Pitel
   
|
 
|
 
|
 
|
|Pending
   
|
 
|
 
|
 
|
Line 2,596: Line 2,426:  
|
 
|
 
|-
 
|-
|MLTT3
+
| Papillary glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,604: Line 2,434:  
|
 
|
 
|
 
|
 +
|-
 +
| Rosette-forming glioneuronal tumour||Disease||
 
|
 
|
|-
  −
|MECOM
  −
|Brian Davis
   
|
 
|
 
|
 
|
|Pending
   
|
 
|
 
|
 
|
Line 2,616: Line 2,444:  
|
 
|
 
|-
 
|-
|FGFR1(FLT2)
+
| Myxoid glioneuronal tumour||Disease||
|Brian Davis
+
|
 
|
 
|
 
|
 
|
|Pending
   
|
 
|
 
|
 
|
Line 2,626: Line 2,453:  
|
 
|
 
|-
 
|-
|KMT2A
+
| Diffuse leptomeningeal glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,634: Line 2,461:  
|
 
|
 
|
 
|
 +
|-
 +
| Multinodular and vacuolating neuronal tumour||Disease||
 
|
 
|
|-
  −
|DEK
  −
|Wahab A. Khan
   
|
 
|
 
|
 
|
|Pending
   
|
 
|
 
|
 
|
Line 2,646: Line 2,471:  
|
 
|
 
|-
 
|-
|NUP214
+
| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
|Wahab A. Khan
+
|
 
|
 
|
 
|
 
|
|Pending
   
|
 
|
 
|
 
|
Line 2,656: Line 2,480:  
|
 
|
 
|-
 
|-
|RBM15
+
| Central neurocytoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,666: Line 2,489:  
|
 
|
 
|-
 
|-
|MKL1
+
| Extraventricular neurocytoma||Disease||
|
  −
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
 
|
 
|
|-
  −
|DDX41
  −
|Ying Zou
  −
|8/7/20
   
|
 
|
|Pending
   
|
 
|
 
|
 
|
Line 2,686: Line 2,498:  
|
 
|
 
|-
 
|-
|ANKRD26
+
| Cerebellar liponeurocytoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,696: Line 2,507:  
|
 
|
 
|-
 
|-
|CUX1
+
| Supratentorial ependymoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,706: Line 2,516:  
|
 
|
 
|-
 
|-
|TET2
+
| Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
|
   
|
 
|
 
|
 
|
Line 2,716: Line 2,525:  
|
 
|
 
|-
 
|-
|EZH2
+
| Supratentorial ependymoma, YAP1 fusion-positive||Disease||
|
   
|
 
|
 
|
 
|
Line 2,726: Line 2,534:  
|
 
|
 
|-
 
|-
|FOXP1
+
| Posterior fossa ependymoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,736: Line 2,543:  
|
 
|
 
|-
 
|-
|MYC
+
| Posterior fossa group A (PFA) ependymoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,746: Line 2,552:  
|
 
|
 
|-
 
|-
|JAK2
+
| Posterior fossa group B (PFB) ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,754: Line 2,560:  
|
 
|
 
|
 
|
 +
|-
 +
| Spinal ependymoma||Disease||
 
|
 
|
|-
  −
|WT1
  −
|DONE
   
|
 
|
 
|
 
|
|DONE
   
|
 
|
 
|
 
|
Line 2,766: Line 2,570:  
|
 
|
 
|-
 
|-
|CBL
+
| Spinal ependymoma, MYCN-amplified||Disease||
|
   
|
 
|
 
|
 
|
Line 2,776: Line 2,579:  
|
 
|
 
|-
 
|-
|NF1
+
| Myxopapillary ependymoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,786: Line 2,588:  
|
 
|
 
|-
 
|-
|SUZ12
+
| Subependymoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,796: Line 2,597:  
|
 
|
 
|-
 
|-
|ERG
+
| Choroid plexus papilloma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,806: Line 2,606:  
|
 
|
 
|-
 
|-
|EST2
+
| Atypical choroid plexus papilloma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,816: Line 2,615:  
|
 
|
 
|-
 
|-
|RPS14
+
| Choroid plexus carcinoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,826: Line 2,624:  
|
 
|
 
|-
 
|-
|RB1
+
| Medulloblastoma, WNT-activated||Disease||
|
   
|
 
|
 
|
 
|
Line 2,836: Line 2,633:  
|
 
|
 
|-
 
|-
|MPL
+
| Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
|
   
|
 
|
 
|
 
|
Line 2,846: Line 2,642:  
|
 
|
 
|-
 
|-
|CHGA
+
| Medulloblastoma, SHH-activated and TP53-mutant||Disease||
|
   
|
 
|
 
|
 
|
Line 2,856: Line 2,651:  
|
 
|
 
|-
 
|-
|CDH1
+
| Medulloblastoma, non-WNT/non-SHH||Disease||
|
   
|
 
|
 
|
 
|
Line 2,866: Line 2,660:  
|
 
|
 
|-
 
|-
|SRSF2
+
| Medulloblastoma, histologically defined||Disease||
|
   
|
 
|
 
|
 
|
Line 2,876: Line 2,669:  
|
 
|
 
|-
 
|-
|DNMT1
+
| Atypical teratoid/rhabdoid tumour||Disease||
|
   
|
 
|
 
|
 
|
Line 2,886: Line 2,678:  
|
 
|
 
|-
 
|-
|PRDX2
+
| Cribriform neuroepithelial tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,894: Line 2,686:  
|
 
|
 
|
 
|
 +
|-
 +
| Embryonal tumour with multilayered rosettes||Disease||
 
|
 
|
|-
  −
|ASXL1
  −
|DONE
   
|
 
|
 
|
 
|
|DONE
   
|
 
|
 
|
 
|
Line 2,906: Line 2,696:  
|
 
|
 
|-
 
|-
|MN1
+
| CNS neuroblastoma, FOXR2-activated||Disease||
|
   
|
 
|
 
|
 
|
Line 2,916: Line 2,705:  
|
 
|
 
|-
 
|-
|SF3A1
+
| CNS tumour with BCOR internal tandem duplication||Disease||
|
   
|
 
|
 
|
 
|
Line 2,926: Line 2,714:  
|
 
|
 
|-
 
|-
|EP300
+
| CNS embryonal tumour NEC/NOS||Disease||
|
   
|
 
|
 
|
 
|
Line 2,936: Line 2,723:  
|
 
|
 
|-
 
|-
|JARID2
+
| Pineocytoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,946: Line 2,732:  
|
 
|
 
|-
 
|-
|BRCA1
+
| Pineal parenchymal tumour of intermediate differentiation||Disease||
|
   
|
 
|
 
|
 
|
Line 2,956: Line 2,741:  
|
 
|
 
|-
 
|-
|BRCA2
+
| Pineoblastoma||Disease||
|
   
|
 
|
 
|
 
|
Line 2,966: Line 2,750:  
|
 
|
 
|-
 
|-
|
+
| Papillary tumour of the pineal region||Disease||
|
   
|
 
|
 
|
 
|
Line 2,976: Line 2,759:  
|
 
|
 
|-
 
|-
 +
| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
 
|
 
|
 
|
 
|
Line 2,983: Line 2,767:  
|
 
|
 
|
 
|
 +
|-
 +
| Schwannoma||Disease||
 
|
 
|
|
  −
|}
  −
  −
==WHO Central Nervous System Tumours  (5th ed.) Content==
  −
  −
  −
{| class="wikitable"
  −
|-
  −
!'''Disease'''!!'''Page Type'''!!'''Author'''
  −
!'''Date Assigned to Author'''
  −
!'''Target Completion Date'''
  −
!'''Author Content (Pending or Complete)'''
  −
!'''Date Completed by Author'''!!'''Associate Editor'''
  −
!'''Date of Last Editor Review'''
  −
!'''Notes'''
  −
|-
  −
|Astrocytoma, IDH-mutant||Disease||
   
|
 
|
 
|
 
|
Line 3,008: Line 2,777:  
|
 
|
 
|-
 
|-
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
+
| Neurofibroma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Glioblastoma, IDH-wildtype||Disease||
   
|
 
|
 
|
 
|
Line 3,024: Line 2,786:  
|
 
|
 
|-
 
|-
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
+
| Perineurioma||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Angiocentric glioma||Disease||
   
|
 
|
 
|
 
|
Line 3,040: Line 2,795:  
|
 
|
 
|-
 
|-
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
+
| Hybrid nerve sheath tumours||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Diffuse low-grade glioma, MAPK pathway-altered||Disease||
   
|
 
|
 
|
 
|
Line 3,056: Line 2,804:  
|
 
|
 
|-
 
|-
|Diffuse midline glioma, H3 K27-altered||Disease||
+
| Malignant melanotic nerve sheath tumour||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
   
|
 
|
 
|
 
|
Line 3,072: Line 2,813:  
|
 
|
 
|-
 
|-
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
+
| Malignant peripheral nerve sheath tumour||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Infant-type hemispheric glioma||Disease||
   
|
 
|
 
|
 
|
Line 3,088: Line 2,822:  
|
 
|
 
|-
 
|-
|Pilocytic astrocytoma||Disease||
+
| Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|High-grade astrocytoma with piloid features||Disease||
   
|
 
|
 
|
 
|
Line 3,104: Line 2,831:  
|
 
|
 
|-
 
|-
|Pleomorphic xanthoastrocytoma||Disease||
+
| Meningioma||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Subependymal giant cell astrocytoma||Disease||
   
|
 
|
 
|
 
|
Line 3,120: Line 2,840:  
|
 
|
 
|-
 
|-
|Chordoid glioma||Disease||
+
| Solitary fibrous tumour||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Astroblastoma, MN1-altered||Disease||
   
|
 
|
 
|
 
|
Line 3,136: Line 2,849:  
|
 
|
 
|-
 
|-
|Ganglioglioma||Disease||
+
| Haemangiomas and vascular malformations||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Gangliocytoma||Disease||
   
|
 
|
 
|
 
|
Line 3,152: Line 2,858:  
|
 
|
 
|-
 
|-
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
+
| Haemangioblastoma||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Dysembryoplastic neuroepithelial tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,168: Line 2,867:  
|
 
|
 
|-
 
|-
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
+
| Rhabdomyosarcoma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Papillary glioneuronal tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,184: Line 2,876:  
|
 
|
 
|-
 
|-
|Rosette-forming glioneuronal tumour||Disease||
+
| Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Myxoid glioneuronal tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,200: Line 2,885:  
|
 
|
 
|-
 
|-
|Diffuse leptomeningeal glioneuronal tumour||Disease||
+
| CIC-rearranged sarcoma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Multinodular and vacuolating neuronal tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,216: Line 2,894:  
|
 
|
 
|-
 
|-
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
+
| Primary intracranial sarcoma, DICER1-mutant||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Central neurocytoma||Disease||
   
|
 
|
 
|
 
|
Line 3,232: Line 2,903:  
|
 
|
 
|-
 
|-
|Extraventricular neurocytoma||Disease||
+
| Ewing sarcoma||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Cerebellar liponeurocytoma||Disease||
   
|
 
|
 
|
 
|
Line 3,248: Line 2,912:  
|
 
|
 
|-
 
|-
|Supratentorial ependymoma||Disease||
+
| Mesenchymal chondrosarcoma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Supratentorial ependymoma, ZFTA fusion-positive||Disease||
   
|
 
|
 
|
 
|
Line 3,264: Line 2,921:  
|
 
|
 
|-
 
|-
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
+
| Chondrosarcoma||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Posterior fossa ependymoma||Disease||
   
|
 
|
 
|
 
|
Line 3,280: Line 2,930:  
|
 
|
 
|-
 
|-
|Posterior fossa group A (PFA) ependymoma||Disease||
+
| Chordoma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Posterior fossa group B (PFB) ependymoma||Disease||
   
|
 
|
 
|
 
|
Line 3,296: Line 2,939:  
|
 
|
 
|-
 
|-
|Spinal ependymoma||Disease||
+
| Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Spinal ependymoma, MYCN-amplified||Disease||
   
|
 
|
 
|
 
|
Line 3,312: Line 2,948:  
|
 
|
 
|-
 
|-
|Myxopapillary ependymoma||Disease||
+
| Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Subependymoma||Disease||
   
|
 
|
 
|
 
|
Line 3,328: Line 2,957:  
|
 
|
 
|-
 
|-
|Choroid plexus papilloma||Disease||
+
| Primary diffuse large B-cell lymphoma of the CNS||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Atypical choroid plexus papilloma||Disease||
   
|
 
|
 
|
 
|
Line 3,344: Line 2,966:  
|
 
|
 
|-
 
|-
|Choroid plexus carcinoma||Disease||
+
| Immunodeficiency-associated CNS lymphomas||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Medulloblastoma, WNT-activated||Disease||
   
|
 
|
 
|
 
|
Line 3,360: Line 2,975:  
|
 
|
 
|-
 
|-
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
+
| Lymphomatoid granulomatosis||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
   
|
 
|
 
|
 
|
Line 3,376: Line 2,984:  
|
 
|
 
|-
 
|-
|Medulloblastoma, non-WNT/non-SHH||Disease||
+
| Intravascular large B-cell lymphoma||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Medulloblastoma, histologically defined||Disease||
   
|
 
|
 
|
 
|
Line 3,392: Line 2,993:  
|
 
|
 
|-
 
|-
|Atypical teratoid/rhabdoid tumour||Disease||
+
| MALT lymphoma of the dura||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Cribriform neuroepithelial tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,408: Line 3,002:  
|
 
|
 
|-
 
|-
|Embryonal tumour with multilayered rosettes||Disease||
+
| Other low-grade B-cell lymphomas of the CNS||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|CNS neuroblastoma, FOXR2-activated||Disease||
   
|
 
|
 
|
 
|
Line 3,424: Line 3,011:  
|
 
|
 
|-
 
|-
|CNS tumour with BCOR internal tandem duplication||Disease||
+
| Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|CNS embryonal tumour NEC/NOS||Disease||
   
|
 
|
 
|
 
|
Line 3,440: Line 3,020:  
|
 
|
 
|-
 
|-
|Pineocytoma||Disease||
+
| T-cell and NK/T-cell lymphomas||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Pineal parenchymal tumour of intermediate differentiation||Disease||
   
|
 
|
 
|
 
|
Line 3,456: Line 3,029:  
|
 
|
 
|-
 
|-
|Pineoblastoma||Disease||
+
| Erdheim-Chester disease||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Papillary tumour of the pineal region||Disease||
   
|
 
|
 
|
 
|
Line 3,472: Line 3,038:  
|
 
|
 
|-
 
|-
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
+
| Rosai-Dorfman disease||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Schwannoma||Disease||
   
|
 
|
 
|
 
|
Line 3,488: Line 3,047:  
|
 
|
 
|-
 
|-
|Neurofibroma||Disease||
+
| Juvenile xanthogranuloma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Perineurioma||Disease||
   
|
 
|
 
|
 
|
Line 3,504: Line 3,056:  
|
 
|
 
|-
 
|-
|Hybrid nerve sheath tumours||Disease||
+
| Langerhans cell histiocytosis||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Malignant melanotic nerve sheath tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,520: Line 3,065:  
|
 
|
 
|-
 
|-
|Malignant peripheral nerve sheath tumour||Disease||
+
| Histiocytic sarcoma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
   
|
 
|
 
|
 
|
Line 3,536: Line 3,074:  
|
 
|
 
|-
 
|-
|Meningioma||Disease||
+
| Germ cell tumours of the CNS||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Solitary fibrous tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,552: Line 3,083:  
|
 
|
 
|-
 
|-
|Haemangiomas and vascular malformations||Disease||
+
| Adamantinomatous craniopharyngioma||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Haemangioblastoma||Disease||
   
|
 
|
 
|
 
|
Line 3,568: Line 3,092:  
|
 
|
 
|-
 
|-
|Rhabdomyosarcoma||Disease||
+
| Papillary craniopharyngioma||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
   
|
 
|
 
|
 
|
Line 3,584: Line 3,101:  
|
 
|
 
|-
 
|-
|CIC-rearranged sarcoma||Disease||
+
| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Primary intracranial sarcoma, DICER1-mutant||Disease||
   
|
 
|
 
|
 
|
Line 3,600: Line 3,110:  
|
 
|
 
|-
 
|-
|Ewing sarcoma||Disease||
+
| Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Mesenchymal chondrosarcoma||Disease||
   
|
 
|
 
|
 
|
Line 3,616: Line 3,119:  
|
 
|
 
|-
 
|-
|Chondrosarcoma||Disease||
+
| Pituitary blastoma||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Chordoma||Disease||
   
|
 
|
 
|
 
|
Line 3,632: Line 3,128:  
|
 
|
 
|-
 
|-
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
+
| Metastases to the brain and spinal cord parenchyma||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
   
|
 
|
 
|
 
|
Line 3,648: Line 3,137:  
|
 
|
 
|-
 
|-
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
+
| Metastases to the meninges||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Immunodeficiency-associated CNS lymphomas||Disease||
   
|
 
|
 
|
 
|
Line 3,664: Line 3,146:  
|
 
|
 
|-
 
|-
|Lymphomatoid granulomatosis||Disease||
+
| Neurofibromatosis type 1||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Intravascular large B-cell lymphoma||Disease||
   
|
 
|
 
|
 
|
Line 3,680: Line 3,155:  
|
 
|
 
|-
 
|-
|MALT lymphoma of the dura||Disease||
+
| Neurofibromatosis type 2||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Other low-grade B-cell lymphomas of the CNS||Disease||
   
|
 
|
 
|
 
|
Line 3,696: Line 3,164:  
|
 
|
 
|-
 
|-
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
+
| Schwannomatosis||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|T-cell and NK/T-cell lymphomas||Disease||
   
|
 
|
 
|
 
|
Line 3,712: Line 3,173:  
|
 
|
 
|-
 
|-
|Erdheim-Chester disease||Disease||
+
| Von Hippel-Lindau syndrome||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Rosai-Dorfman disease||Disease||
   
|
 
|
 
|
 
|
Line 3,728: Line 3,182:  
|
 
|
 
|-
 
|-
|Juvenile xanthogranuloma||Disease||
+
| Tuberous sclerosis||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Langerhans cell histiocytosis||Disease||
   
|
 
|
 
|
 
|
Line 3,744: Line 3,191:  
|
 
|
 
|-
 
|-
|Histiocytic sarcoma||Disease||
+
| Li-Fraumeni syndrome||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Germ cell tumours of the CNS||Disease||
   
|
 
|
 
|
 
|
Line 3,760: Line 3,200:  
|
 
|
 
|-
 
|-
|Adamantinomatous craniopharyngioma||Disease||
+
| Cowden syndrome||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Papillary craniopharyngioma||Disease||
   
|
 
|
 
|
 
|
Line 3,776: Line 3,209:  
|
 
|
 
|-
 
|-
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
+
| Constitutional mismatch repair deficiency syndrome||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
   
|
 
|
 
|
 
|
Line 3,792: Line 3,218:  
|
 
|
 
|-
 
|-
|Pituitary blastoma||Disease||
+
| Familial adenomatous polyposis 1||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Metastases to the brain and spinal cord parenchyma||Disease||
   
|
 
|
 
|
 
|
Line 3,808: Line 3,227:  
|
 
|
 
|-
 
|-
|Metastases to the meninges||Disease||
+
| Naevoid basal cell carcinoma syndrome||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Neurofibromatosis type 1||Disease||
   
|
 
|
 
|
 
|
Line 3,824: Line 3,236:  
|
 
|
 
|-
 
|-
|Neurofibromatosis type 2||Disease||
+
| Rhabdoid tumour predisposition syndrome||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|Schwannomatosis||Disease||
   
|
 
|
 
|
 
|
Line 3,840: Line 3,245:  
|
 
|
 
|-
 
|-
|Von Hippel-Lindau syndrome||Disease||
+
| Carney complex||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Tuberous sclerosis||Disease||
   
|
 
|
 
|
 
|
Line 3,856: Line 3,254:  
|
 
|
 
|-
 
|-
|Li-Fraumeni syndrome||Disease||
+
| DICER1 syndrome||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|Cowden syndrome||Disease||
   
|
 
|
 
|
 
|
Line 3,872: Line 3,263:  
|
 
|
 
|-
 
|-
|Constitutional mismatch repair deficiency syndrome||Disease||
+
| Familial paraganglioma syndromes||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|Familial adenomatous polyposis 1||Disease||
   
|
 
|
 
|
 
|
Line 3,888: Line 3,272:  
|
 
|
 
|-
 
|-
|Naevoid basal cell carcinoma syndrome||Disease||
+
| Melanoma-astrocytoma syndrome||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Rhabdoid tumour predisposition syndrome||Disease||
   
|
 
|
 
|
 
|
Line 3,904: Line 3,281:  
|
 
|
 
|-
 
|-
|Carney complex||Disease||
+
| Familial retinoblastoma||Disease||
|
   
|
 
|
|
  −
|
  −
|
  −
|
  −
|-
  −
|DICER1 syndrome||Disease||
   
|
 
|
 
|
 
|
Line 3,920: Line 3,290:  
|
 
|
 
|-
 
|-
|Familial paraganglioma syndromes||Disease||
+
| BAP1 tumour predisposition syndrome||Disease||
|
  −
|
  −
|
  −
|
  −
|
   
|
 
|
|-
  −
|Melanoma-astrocytoma syndrome||Disease||
   
|
 
|
 
|
 
|
Line 3,936: Line 3,299:  
|
 
|
 
|-
 
|-
|Familial retinoblastoma||Disease||
+
| Fanconi anaemia||Disease||
|
  −
|
  −
|
  −
|
   
|
 
|
|
  −
|-
  −
|BAP1 tumour predisposition syndrome||Disease||
   
|
 
|
 
|
 
|
Line 3,952: Line 3,308:  
|
 
|
 
|-
 
|-
|Fanconi anaemia||Disease||
+
| ELP1-medulloblastoma syndrome||Disease||
|
  −
|
   
|
 
|
|
  −
|
  −
|
  −
|-
  −
|ELP1-medulloblastoma syndrome||Disease||
   
|
 
|
 
|
 
|
Line 3,968: Line 3,317:  
|
 
|
 
|-
 
|-
|}
+
}